Helix

#InTheNews: Big news from #ASHG2024! Researchers at Helix have unveiled a novel precision effectiveness model to predicts the 12-month weight loss response of Semaglutide in diverse populations. This model could be used to identify individuals most likely to respond to treatment, improve shared decision making around best individual treatments for obesity, estimates of expected weight loss over time and more. This research was made possible by the Helix Research Network, the largest and fastest growing precision clinical research network to help advance genetic and health insights. Read more here and learn about all of the research presented at ASHG this year: https://bit.ly/4fC9fAU #Research #Genetics #Genomics #PrecisionMedicine #ClinicalResearch #Obesity

Join us for our panel that will explore how St. Luke's University Health Network and WellSpan Health are currently leveraging genomics within their organizations. The panel will be held tomorrow – Wednesday, November 13th – at 10:40am in the Grand MN Room at the Becker's Healthcare CEO + CFO Roundtable. Don't miss this opportunity to discuss how to develop a large-scale genomics strategy that aligns with your health system’s vision and goals. Visit booth #208 to meet our team and learn more. https://bit.ly/3OoWkXr

It's #ASHG week! Join us live from Nov 5-9th in Denver as our experts deliver innovative insights with the power of a precision clinical research network in a diverse range of therapeutic areas. Several of our talks include CME credits: ✳️ Weight loss with #semaglutide influenced by traditional metabolic risk factors and BMI-associated genetic variants 〽️ Classification of rare non-synonymous variants to identify individuals at low risk of disease: introducing variants of potential risk 🔎 Comparing scalable and automated vs. ACMG/AMP variant interpretation strategies for #BRCA1 and #BRCA2 in a large clinico-genomic cohort from six US-based health systems Check out the full list of posters and presentations here: https://bit.ly/4hy9NJw Come by and say hello at Booth #970! #HumanGenetics #research #Genomics #Exome#PrecisionMedicine hashtag#DrugDiscovery #Research

Honored to have won this 2024 Illumi award for our UX research work this past year, showcasing how we leveraged user testing insights to improve the enrollment experience for our health system partners. Read more about what our amazing teams accomplished together here: https://lnkd.in/e2c96gnH #THiS24, #usertesting, #research, #awards, #enrollment

We’re less than a week out from #ASHG2024! We’re excited to showcase Helix and the impact of clinico-genomic research on clinical care and drug discovery in a range of therapeutic areas. Don’t miss platform talks and poster sessions on predictors of future risk for cardiovascular disease, genetic and metabolic factors associated with weight loss while on semaglutide, and the impact of foregoing routine pharmacogenetic testing on major adverse events and more. Visit us at booth #970 to explore how #genomics is shaping the future of healthcare. For more info, read our full announcement: https://hubs.ly/Q02WlR6k0 #HumanGenetics #Geneticsresearch #Genomics #Exome #PrecisionMedicine #DrugDiscovery #Research

Proud of our partner WellSpan Health's progress with their community health research program, the Gene Health Project. Enrolling 25,000 participants surpasses their annual goals with this joint population genomics effort that will transform health care delivery and outcomes. WellSpan is leading the way into a future of more personalized medicine for all.

ASHG is coming up fast from Nov 5-9th and we're excited to be a part of it! This year, we are featuring exciting human genetics research across a broad range of topics. Join Dr. Matt Levy, Senior Research Scientist from Helix on 11/8 at 11:30am MT as he talks about traditional metabolic risk factors and BMI-associated #genetic variants influencing weight loss with #Semaglutide treatment. Unable to make the talk? Stop by Booth #970 11/7 at 3:30pm MT and 11/8 at 12:15pm to speak with Dr. Levy! Checkout all of our presentations here https://hubs.ly/Q02VJlSn0 #genomics #genetics #ashg2024 #research #semaglutide #drugdiscovery

We're excited to be at #ASHG2024 in Denver, Colorado from November 5th-9th! Delivering innovative insights from the Helix Research Network, this year features research presentations from our scientific experts (Daniela Iacoboni, Alexandre Bolze, Matt Levy, Kelly Schiabor Barrett, Nicole Washington, Natalie Telis, Liz Cirulli, Akwasi A Asabere, Ph.D) on a broad range of key topics including: 〽️ Retrospective study showing #pharmacogenomic testing could reduce adverse events associated with #Clopidogrel use by 38% 🔎 Predicting coronary artery disease using an #exome based estimate of KIV-2 repeat count in the Lp(a) gene ✳️ Weight loss with #semaglutide influenced by traditional metabolic risk factors and BMI-associated genetic variants And many other topics! Check out the full list of posters and presentations here: https://bit.ly/3zTZ8YW Come by and say hello and learn more at Booth #970! #HumanGenetics #Geneticsresearch #Genomics #Exome #PrecisionMedicine #DrugDiscovery #Research

User research and testing is core to how we create better healthcare experiences at Helix for our customers—driving improved engagement and accessibility for life-saving DNA insights. #HealthcareInnovation #UserResearch #Genomics #PatientExperience

#InTheNews: Did you know that genetic factors play a role in up to 10% of all cases of breast and ovarian cancer? A new study in JAMA Network Open we worked on reveals that many patients are unaware they carry genetic risk factors for these diseases. Our study partner, Joseph Grzymski, Chief Genomics Officer at Renown Health, discussed these findings with Maggie McGrath of ForbesWomen, highlighting what this means for both patients and providers across the U.S. Watch the full interview to learn more about the impact of genetic screening, cost barriers, and what's next in cancer prevention efforts. https://bit.ly/486nqv7 #BreastCancerAwareness #GeneticScreening #WomensHealth #CancerPrevention